Stay updated on Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.7.0 was added to the study documents section, replacing the previous Revision: v3.6.6.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.6.6 has been added and the previous Revision: v3.6.5 has been removed, indicating a minor update to the page's underlying build.SummaryDifference0.0%

- Check25 days agoChange DetectedAn NIH grant/contract attribution for 2016 was added to the study's identifiers. This documents the funding source supporting the trial.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4 on the page, representing a small update to the page's revision metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This indicates a minor update to the page's metadata or documentation rather than changes to the study content displayed to users.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, signaling a new deployment. This update does not modify the study details or other content visible to users.SummaryDifference0.0%

Stay in the know with updates to Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.